Education Section Sponsorship
Position your client as a strategic partner with pharmacists by sponsoring an educational section in the AJP.
Each section of the following educational sections is approved by the Australian College of Pharmacy Practice and Management and the Pharmaceutical Society of Australia to enable pharmacists to meet their continuing professional development (CPD) commitments. Each section is independently researched and written by an acknowledged expert in their field of study.
Company sponsors are acknowledged on every page or double-page spread with their company name and logo.
Specialty Practice Series
Your chance to initiate pharmacist education!
Focuses on the latest treatment developments in a particular disease state or area of pharmacy specialisation. The topic of the article and the authors or consulting authors may be nominated by the sponsoring company, but must be independent of that company and an acknowledged specialist in their field of expertise.
EXTENT: 4 PAGES.
Copy deadline for Specialty Practice Series sponsorship: 6 weeks prior to the month of publication (e.g. 15 February for April issue).
Booking deadline: 8 weeks prior.
Disease State Management
Always or nearly always read by 90% of readers in every issue, Disease State Management is written by Honorary Associate Professor Louis Roller, Department of Pharmacy Practice, Faculty of Pharmacy and Pharmaceutical Sciences, Monash University and leading pharmacy educator, and consultant pharmacist Dr Jenny Gowan.
This regular section offers counselling and treatment advice focusing on specific disease states and medication management.
EXTENT: MINIMUM OF 4 PAGES.
Current Drug Information (CDI)
More than 90% of AJP readers always or nearly always read CDI in every issue. Written by AJP consultant editor, Dr Jack Thomas OA, CDI is a monthly round-up of reviews, analysis and commentary of new drugs or new drug information.
EXTENT: MINIMUM OF 6 PAGES.
SPONSORSHIP RATES
Specialty Practice Series |
$6,200 per issue |
Disease State Management |
$4,280 per issue |
Current Drug Information |
$4,280 per issue |
|